About Low Dose Ketamine
Independent, evidence-forward writing about low-dose ketamine therapy — with citations, monitoring boundaries, and explicit uncertainty.
Our editorial standard
What this site is
Low Dose Ketamine is an independent reference site focused specifically on low-dose ketamine therapy: the routes, doses, conditions, and monitoring practices covered in the peer-reviewed literature.
We write long-form material — comprehensive guides, condition-specific writeups, dosing references, and protocol explainers — for readers who need more than a marketing page.
What this site is not
We are not a clinic, a telehealth provider, or a referral service. We do not diagnose, prescribe, or treat. Articles here describe how ketamine therapy is studied and used; they do not replace evaluation by a qualified clinician.
How we write
- Each guide cites the primary literature it relies on.
- We separate FDA-approved esketamine from off-label racemic ketamine because the evidence and regulatory status differ.
- We surface monitoring expectations — what a careful clinician should be tracking — alongside the dosing discussion.
- We update articles when new evidence materially changes the picture, and date the last review.
Disclosures
We accept no payment from clinics, manufacturers, or telehealth providers in exchange for coverage. The advertising page describes the few ways the site is supported.
Editorial corrections welcome
If you find an error or believe an article needs updating in light of new evidence, please write to us — we treat every correction request seriously.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.